lung cancer

Immune cells form different communities throughout a tumor, potentially disrupting how cancers respond to treatments.

Mouse models mimicking the transition from a common form of lung cancer to a more aggressive one may help scientists develop future strategies to prevent this transformation.

Researchers studying lung cancer cell lines found that chromatin remodeling underlies one type of osimertinib resistance.

Khalid Shah engineers stem cells to deliver cancer therapeutics directly to tumors, thereby increasing their efficacy.

Probing the protein landscape in lung cancers reveals new therapeutic insights.

From 2017 to 2018, cancer deaths dropped by 2.4 percent, the largest single-year improvement recorded in 70 years of American Cancer Society annual cancer reports.

An artificial intelligence program called a neural network exceeds radiologists’ ability to detect malignancies, but more testing is needed before using the program clinically.

Human lung cancer cells can form an invasive pack that coordinates its movement during metastasis.  

The scientist and clinician helped develop a new form of cancer therapy, using a monoclonal antibody to treat head, neck, colorectal, and lung cancers.

Better treatment and diagnoses have helped more people survive, but economic disparities in outcomes for some preventable cancers have gotten worse.

A small, in vitro study concludes that e-cigarette vapor harms macrophages taken from human lung tissue.

Merck’s Keytruda extended the lives of lung cancer patients by several months and appeared to stop the progression of advanced melanoma.  

The test can pick up several types of cancer, including pancreatic and ovarian, years before symptoms appear.

Pembrolizumab combined with chemotherapy nearly doubles survival rates and shrinks tumors in some individuals.

By removing a single gene, researchers change the developmental fate of tumor cells in mice.  

The new diagnostic works by identifying cancer-associated proteins and DNA in patient blood.